---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-011228"
form_type: "8-K"
ticker: "KYMR"
cik: "0001815442"
company_name: "Kymera Therapeutics, Inc."
filed_at: "2022-01-18T23:59:59+00:00"
generated_at: "2026-06-27T17:38:59.870974+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Kymera Therapeutics appoints John Maraganore, Ph.D. to Board of Directors

## Summary
- John Maraganore, Ph.D. appointed to Kymera's Board effective January 17, 2022.
- Dr. Maraganore will serve as a Class III director with term expiring at 2023 annual meeting.
- Board determined Maraganore is independent under Nasdaq listing standards; committee compositions unchanged.
- As non-employee director, he will receive cash and equity per Company's Non-Employee Director Compensation Policy.
- No transactions requiring disclosure per Item 404(a) and no arrangements with others for selection.

## SEC filing metadata
- accession: 0001193125-22-011228
- form_type: 8-K
- ticker: KYMR
- cik: 0001815442
- company_name: Kymera Therapeutics, Inc.
- filed_at: 2022-01-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815442/000119312522011228/0001193125-22-011228-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815442/000119312522011228/d297242d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-011228
- JSON: https://secwatch.observer/filing/0001193125-22-011228.json
- Plain text: https://secwatch.observer/filing/0001193125-22-011228.txt

## Key facts
- Executive change
  John Maraganore was appointed as Director at Kymera Therapeutics, Inc..
  - Action: appointed
  - Role: Director
  source text: the Board appointed John Maraganore, Ph.D. to join the Board, effective as of January 17, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1815442/000119312522011228/0001193125-22-011228-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.